Miller, 2008 - Google Patents
" The New England Journal of Medicine" published a study that seems to question the effectiveness of antidepressants. Is that correct? What does it mean about …Miller, 2008
- Document ID
- 5945609119533328180
- Author
- Miller M
- Publication year
- Publication venue
- The Harvard mental health letter
External Links
- 230000001430 anti-depressive 0 title description 9
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying, e.g. spreading, media, e.g. remedies, on the human body ; Introducing media, e.g. remedies, into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infra-red
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200802204A1 (en) | APPLICATION OF DPP IV INHIBITORS | |
| UY32177A (en) | TREATMENT OF DIABETES IN PATIENTS WITH INSUFFICIENT GLUCEMIC CONTROL TO WEIGHT THERAPY WITH DRUG, ORAL OR NOT, ANTIDIABÉTICO | |
| MX2009011444A (en) | Titration of tapentadol. | |
| MX2009002196A (en) | Buprenophine-wafer for drug substitution therapy. | |
| BRPI0820800A2 (en) | Implantable medical device for controlled drug delivery and methods for administering a drug to a patient's bladder and treating a patient's bladder | |
| MX2013013809A (en) | Expandable devices coated with a paclitaxel composition. | |
| ATE457166T1 (en) | ORAL COMPOSITIONS FOR TREATING DIABETES | |
| EA201791669A3 (en) | NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF SMT AND RELATED DISORDERS | |
| EA201270221A1 (en) | TREATMENT OF CROWN DISEASE WITH LACQUINIMODE | |
| MX2010005631A (en) | Novel cyclic hydrocarbon compounds for the treatment of diseases. | |
| BR112012030641B8 (en) | Uses and compositions for oral pharmaceutical therapy | |
| MX2008013635A (en) | Use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders. | |
| EA200970345A1 (en) | TREATMENT OF HYPERBILIRUBINEMIA OF NEWBORNS WITH THE USE OF LOW DOSING OF STANNSOPORFIN | |
| MX2013013808A (en) | Expandable devices coated with a rapamycin composition. | |
| JP2019529569A5 (en) | ||
| Miller | " The New England Journal of Medicine" published a study that seems to question the effectiveness of antidepressants. Is that correct? What does it mean about continuing the antidepressant I am taking? | |
| JP2016504361A5 (en) | ||
| WO2008064138A3 (en) | Personalized therapeutic treatment process | |
| EA201000739A1 (en) | NEW MEDICAL APPLICATION OF SALTS 3- (2,2,2-TRIMETHYL HYDRAZINIUM) PROPIONATE | |
| Baughman | Treatment of sarcoidosis | |
| Khatun et al. | Clinical outcomes of management of myofacial pain dysfunction syndrome | |
| RU2008107113A (en) | MEANS AND METHOD FOR PREVENTION AND TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE | |
| Chambers | substitution from piperacillin-tazobactam to cefepime and metronidazole. 20th European Congress of Clinical Microbiology and Infectious Diseases: 10 Apr 2010. Available from: URL: http://www. congrex. ch/eccmid2010 803017768 | |
| Furuta | Drug allergy and bronchial asthma: 2 case reports | |
| Lee et al. | Ask the doctors. My potassium level is high, and my physician stopped the medication that has successfully controlled my blood pressure for years, lisinopril. What is the danger from high potassium, and why is lisinopril a problem? |